Biogen Inc.
BIIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22,280 | $37,444 | $40,236 | $35,772 |
| - Cash | $2,375 | $1,050 | $3,419 | $2,261 |
| + Debt | $6,630 | $7,338 | $6,614 | $7,604 |
| Enterprise Value | $26,536 | $43,732 | $43,431 | $41,114 |
| Revenue | $9,676 | $9,836 | $10,173 | $10,982 |
| % Growth | -1.6% | -3.3% | -7.4% | – |
| Gross Profit | $7,366 | $7,302 | $7,895 | $8,872 |
| % Margin | 76.1% | 74.2% | 77.6% | 80.8% |
| EBITDA | $2,996 | $2,377 | $3,537 | $3,923 |
| % Margin | 31% | 24.2% | 34.8% | 35.7% |
| Net Income | $1,632 | $1,161 | $3,047 | $1,556 |
| % Margin | 16.9% | 11.8% | 29.9% | 14.2% |
| EPS Diluted | 11.19 | 7.97 | 20.87 | 10.4 |
| % Growth | 40.4% | -61.8% | 100.7% | – |
| Operating Cash Flow | $2,876 | $1,547 | $1,384 | $3,640 |
| Capital Expenditures | -$360 | -$311 | -$240 | -$258 |
| Free Cash Flow | $2,516 | $1,236 | $1,144 | $3,382 |